TempraMed signs LOI with CPO Cyprus for exclusive distribution of VIVI products in Cyprus

• TempraMed signed a non-binding LOI with CPO Cyprus for exclusive distribution of VIVI Cap and VIVI Epi in Cyprus.
• Exclusivity would hinge on minimum annual purchase commitments, with combined volumes required to rise at least 20% year over year.
• Transfer pricing, first-year minimum unit commitments slated for negotiation in a definitive distribution agreement.
• Parties set a 90-day window from July 31, 2026 to finalize terms, subject to any mutually agreed extension.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609290305NEWSFILECNPR____20260929_316370_1) on September 29, 2026, and is solely responsible for the information contained therein.